Niagen Bioscience (NAGE) Deferred Taxes (2011 - 2026)
Niagen Bioscience (NAGE) posted quarterly Deferred Taxes of $41000.0 for Q1 2026, up 356.25% quarter-over-quarter from -$16000.0 in Q4 2018.
Analysis
Niagen Bioscience (NAGE) Deferred Taxes (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has reported Deferred Taxes for 7 consecutive years, with $41000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Deferred Taxes changed N/A year-over-year to $41000.0; the TTM figure through Mar 2026 stood at $41000.0 (changed N/A YoY), while the FY2018 annual figure was $2000.0, down 98.89% from the prior year.
- Deferred Taxes climbed to $41000.0 in Q1 2026 per NAGE's latest filing, from -$16000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $41000.0 in Q1 2026 and bottomed at $41000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Niagen Bioscience | 251.05 Mn | 184.31 Mn | 19.31 Mn | 1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 41,000.00 |
| Dec 31, 2018 | -16,000.00 |
| Sep 30, 2018 | -8,000.00 |
| Jun 30, 2018 | 76,000.00 |
| Mar 31, 2018 | -50,000.00 |
| Dec 30, 2017 | -8,000.00 |
| Sep 30, 2017 | 168,000.00 |
| Jul 1, 2017 | -20,000.00 |
| Apr 1, 2017 | 40,000.00 |
| Dec 31, 2016 | 321,037.00 |
| Oct 1, 2016 | 75,977.00 |
| Jul 2, 2016 | 125,514.00 |
| Apr 2, 2016 | -18,857.00 |
| Jan 2, 2016 | -32,713.00 |
| Mar 30, 2013 | -15,621.00 |
| Dec 29, 2012 | -14,849.00 |
| Sep 29, 2012 | -14,849.00 |
| Jun 30, 2012 | -14,223.00 |
| Mar 31, 2012 | -15,811.00 |